Octapharma AG Sustainability Reports
Octapharma AG develops and produces human proteins from human plasma and human cell lines. Its products are used globally across immunotherapy, haematology, and critical care therapeutic areas.
Sector: Manufacturing
Country: Switzerland
Exchange: Unlisted
LEI: 506700X9Q6S71RC33221
15 reports from 2018 to 2025
